In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells

被引:26
作者
Breborowicz, A
Rodela, H
Karon, J
Martis, L
Oreopoulos, DG
机构
[1] BAXTER HEALTHCARE CORP,MCGAW PK,IL
[2] UNIV TORONTO,DIV NEPHROL,TORONTO,ON,CANADA
关键词
peritoneal mesothelium; dialysis fluid; metabolic activity;
D O I
10.1016/S0272-6386(97)90202-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
All previous in vitro biocompatibility tests of peritoneal dialysis fluids have shown that these have inhibitory effects on the function of peritoneal mesothelium. This report presents results from in vitro experiments performed to study the effect of dialysis fluids (Dianeal 1.36 and Dianeal 3.86; Baxter, Round Lake, IL) on the function of mesothelial cells under conditions that simulate the in vivo state of these solutions in the peritoneal cavity, Thus, cells were initially exposed only to the unused fluids that were thereafter gradually diluted (over 4 hours) with pooled effluent dialysate from continuous ambulatory peritoneal dialysis patients, During the following 20 hours, cells were incubated in a mixture of unused fluid (10% vol/vol) and dialysate effluent (90% vol/vol), The mesothelial cells exposed to dialysis fluids under such conditions became activated cells compared with exposed to dialysate effluent (control) alone, Thus, synthesis by mesothelial cells of all tested substances was enhanced during exposure of the mesothelium to the dialysis fluids: interleukin-6: Dianeal 1.36, +257%; Dianeal 3.86, +181% (both P < 0.05); hyaluronic acid: Dianeal 1.36, +72%; Dianeal 3.85, +63% (both P < 0.05); tissue plasminogen activator: Dianeal 3.86, +33% (P < 0.05); and plasminogen activator/inhibitor-1: Dianeal 1.36, +28%; Dianeal 3.86, +38% (both P < 0.05), Our results show that the peritoneal mesothelium becomes activated when it is exposed to acidic, hyperosmotic dialysis fluids diluted with the dialysate effluent, in a manner that imitates the in vivo changes in these solutions during their intraperitoneal dwell. (C) 1997 by the National Kidney Foundation, Inc.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 21 条
[1]   TOXICITY OF OSMOTIC SOLUTES ON HUMAN MESOTHELIAL CELLS-INVITRO [J].
BREBOROWICZ, A ;
RODELA, H ;
OREOPOULOS, DG .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1280-1285
[2]  
BREBOROWICZ A, 1995, ADV PERIT DIAL, V15, P15
[3]   ANISOSMOTIC CELL-VOLUME REGULATION - A COMPARATIVE VIEW [J].
CHAMBERLIN, ME ;
STRANGE, K .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02) :C159-C173
[4]  
DIPAOLO N, 1988, PERITONEAL DIALYSIS, P3
[5]  
DOBBIE JW, 1995, PERIT DIAL INT S, V15, pS87
[6]  
DOUVDEVANI A, 1995, J AM SOC NEPHROL, V6, P207
[7]   CYTOTOXICITY OF COMMERCIAL PERITONEAL-DIALYSIS SOLUTIONS TOWARDS PERITONEAL-CELLS OF CHRONICALLY UREMIC MICE [J].
GALLIMORE, B ;
GAGNON, RF ;
STEVENSON, MM .
NEPHRON, 1986, 43 (04) :283-289
[8]  
GAZZOLA G, 1991, Cellular Physiology and Biochemistry, V1, P131, DOI 10.1159/000154601
[9]   INTRAPERITONEAL SECRETION OF INTERLEUKIN-6 DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
GOLDMAN, M ;
VANDENABEELE, P ;
MOULART, J ;
AMRAOUI, Z ;
ABRAMOWICZ, D ;
NORTIER, J ;
VANHERWEGHEM, JL ;
FIERS, W .
NEPHRON, 1990, 56 (03) :277-280
[10]   THE CYTOCHEMICAL PROFILE OF VISCERAL MESOTHELIUM UNDER THE INFLUENCE OF LACTATED-HYPEROSMOLAR PERITONEAL-DIALYSIS SOLUTIONS [J].
GOTLOIB, L ;
SHOSTAK, A ;
WAJSBROT, V ;
KUSCHNIER, R .
NEPHRON, 1995, 69 (04) :466-471